← Back to Clinical Trials
Recruiting NCT06921161

NCT06921161 Effectivity of TongueFit, A Novel Orofacial Manometer, as Tongue Strength and Endurance Therapy in Children With Dysphagia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06921161
Status Recruiting
Phase
Sponsor Rizky Kusuma Wardhani
Condition Dysphagia
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-03-01
Primary Completion 2025-04-30

Trial Parameters

Condition Dysphagia
Sponsor Rizky Kusuma Wardhani
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 3 Years
Max Age 16 Years
Start Date 2025-03-01
Completion 2025-04-30
All Conditions
Interventions
TongueFitOSMS

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The tongue plays a crucial role in the swallowing process, and weakness in its muscles can lead to difficulties in bolus control, mastication, bolus transport, and oral residue. Reduced tongue strength is closely associated with dysphagia, a swallowing disorder that impairs the movement of food or liquids from the mouth, pharynx, or esophagus into the stomach. Measuring tongue strength is essential not only for diagnosing dysphagia but also for setting therapeutic goals and evaluating treatment effectiveness. However, Indonesia currently lacks accessible tools for assessing tongue strength and endurance or for providing tongue exercise therapy. Existing devices, such as the Tongueometer and Iowa Oral Performance Instrument (IOPI), are costly, difficult to access, and not well-suited for children. To address this gap, a prototype orofacial manometer (PMO) is needed-one that is affordable, child-friendly, and easy to use. TongueFit is an innovative orofacial manometer designed for both assessing and improving tongue strength and endurance. Similar to the IOPI, this prototype provides objective measurements while also incorporating a biofeedback feature in the form of a video game, enhancing engagement and participation in therapy, particularly for children. Additionally, TongueFit offers advantages in affordability, accessibility, and usability. It has been validated as a reliable and accurate tool for measuring tongue function. Given its potential, clinical trials are essential to evaluate the effectiveness of TongueFit in tongue strength and endurance therapy. These trials will support its broader clinical application and development, ensuring that it becomes a widely available tool for dysphagia management.

Eligibility Criteria

Inclusion Criteria: * Children aged 3 to 16 years. * Diagnosed with oral phase dysphagia based on VFSS, with an MBSImP score greater than 0 and ≤12. * Ability to understand and follow instructions. * Adequate postural control, demonstrated by the ability to maintain a sitting position and support the head. * Good jaw stability (absence of open jaw posture, adequate lip seal). * Parental consent and/or patient willingness to participate, confirmed through signed informed consent. Exclusion Criteria: * Children with multiple congenital craniomaxillofacial abnormalities. * Children using visual aids (glasses) or hearing aids. * Children with comorbid conditions that may deteriorate unpredictably. * Patients currently receiving inpatient treatment. * Children who are uncooperative during the training process.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology